Supplemental material
Journal of Medical Economics
Volume 23, 2020 - Issue 6
Open access
1,968
Views
1
CrossRef citations to date
0
Altmetric
Rheumatology
A budget impact analysis for making treatment decisions based on anti-cyclic citrullinated peptide (anti-CCP) testing in rheumatoid arthritis
Sang Hee ParkPharmerit North America LLC – Modeling and Meta-Analysis, Bethesda, MD, USA;
, Xue HanBristol-Myers Squibb Co – US Health Economics and Outcomes Research, Lawrence Township, NJ, USACorrespondence[email protected]
, Francis LoboBristol-Myers Squibb Co – US Health Economics and Outcomes Research, Lawrence Township, NJ, USA
, David KratochvilPharmerit North America LLC – Modeling and Meta-Analysis, Bethesda, MD, USA;
& Dipen PatelPharmerit North America LLC – Modeling and Meta-Analysis, Bethesda, MD, USA;
Pages 624-630
|
Received 13 Jan 2020, Accepted 17 Feb 2020, Published online: 19 May 2020
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.